MRK

Merck & Co
NYSE

Real-time Quotes | Nasdaq Last Sale

76.73
+0.04
+0.05%
After Hours: 76.80 +0.07 +0.09% 17:09 07/10 EDT
OPEN
76.75
PREV CLOSE
76.69
HIGH
77.35
LOW
76.40
VOLUME
4.92M
TURNOVER
--
52 WEEK HIGH
92.64
52 WEEK LOW
65.25
MARKET CAP
193.67B
P/E (TTM)
19.30
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 19 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average MRK stock price target is 93.00 with a high estimate of 107.00 and a low estimate of 84.00.

EPS

MRK News

More
Merck's Keytruda Gets Priority Review for Lymphoma Indication
Zacks · 5h ago
FDA OKs Merck Animal Health one-month chews for fleas and ticks
The FDA approves Merck Animal Health's (NYSE:MRK) Bravecto 1-Month (fluralaner) Chews for dogs and puppies at least eight weeks old for the prevention of f
seekingalpha · 19h ago
Trump Will Sign Three Executive Orders On Lowering Prescription Drug Prices
-Reuter
Reuter · 23h ago
Merck Animal Health Receives U.S. FDA Approval of BRAVECTO® (fluralaner) Monthly Chews
Business Wire · 23h ago
Merck Animal Health Receives FDA Approval Of BRAVECTO Monthly Chews
Portfolio Expansion Ensures Dogs and Puppies 8 Weeks of Age and Older Receive Early, Broad-Spectrum Protection Against Fleas and Ticks MADISON, N.J.--(BUSINESS WIRE)-- Merck Animal Health, known as MSD Animal Health
Benzinga · 1d ago
Coronavirus update: Florida sees deadliest day yet as US cases spike, economy jitters grow
The U.S. saw yet another day of record coronavirus casualties on Thursday, led mostly by a relentless surge in the stricken Sun Belt region.
Yahoo Finance · 1d ago
Coronavirus vaccine makers to testify before U.S. House committee
Reuters · 1d ago
Merck nabs accelerated review in U.S. for Keytruda for second-line cHL
Under Priority Review status, the FDA has accepted for review Merck's (NYSE:MRK) supplemental marketing application seeking approval of Keytruda (pembroliz
seekingalpha · 1d ago

Industry

Pharmaceuticals
-0.37%
Pharmaceuticals & Medical Research
-0.48%

Hot Stocks

Symbol
Price
%Change

About MRK

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.
More

Webull offers kinds of Merck & Co., Inc. stock information, including NYSE:MRK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MRK stock methods without spending real money on the virtual paper trading platform.